Real-world Evidence for Drugs, Biologics, and Devices - REdI 2020
Published 2020-08-31Download video
Recommendations
-
49:07 Restructure of the Office of New Drugs (OND) - REdI 2020
-
03:56 FDA CDER Regulatory Science: Real World Evidence
-
3:46:10 An Introduction to the CDER Quantitative Medicine Center of Excellence
-
02:04 Opioid Use Disorder, New Biosimilar, Black Family Cancer Awareness Week, & more | In Your Day Ep. 6
-
01:48 The Future of Clinical Trials, The Real Cost Campaign, and Sun Safety Tips | FDA In Your Day Ep. 5
-
23:33 LACF and Acidified Foods Regulations and Requirements
-
2:26:13 Redesigned Pre-Submission Meetings in GDUFA III: Benefits for ANDA Submission and Approval
-
7:00:43 185th Meeting of Vaccines and Related Biological Products Advisory Committee
-
00:26 Waterproof Sunscreen? Sun Safety Tips from Episode 5 of FDA In Your Day | Full Video on Channel
-
05:28 Episode 5 - On The Road with Jim Jones - April 2024
-
7:33:16 May 24, 2024 Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) Meeting
-
00:17 Can Cardiac "Organ on a Chip" Technology Help Drug Toxicology Researchers? (Full Video on Channel)
-
6:04:12 REdI Annual Conference 2024: CBER (Biologics) Innovation in Medical Product Development (Day 1 of 2)
-
7:26:41 June 10, 2024 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee (PCNS)
-
9:44:21 June 4, 2024 Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC)
-
49:45 Framework for FDA’s Real-World Evidence Program – Mar 15, 2019
-
1:12:24 Strategies to Increase Clinical Trial Participation for Diverse Communities: OMHHE REACH Consortium
-
01:33 Can Cardiac "Organ on a Chip" Technology Help Drug Toxicology Researchers? | Researching FDA
-
1:31:19 4th Annual National Black Family Cancer Awareness, Engaging the Generations, #BlackFamCan
-
7:42:03 REdI Annual Conference 2024: CBER (Biologics) Innovation in Medical Product Development (Day 2 of 2)
Similar videos
-
18:13 Introduction To Real-World Evidence
-
27:06 MDUFA IV: Accessing and Using Real-World and Postmarket Data for Regulatory Decision-Making
-
02:31 What is Real-World Evidence?
-
12:01 Real-world evidence generation with David Thompson
-
03:48 Real world evidence: what is it and what can it tell us?
-
01:10 Generate Real World Evidence with Clinerion Real World Data
-
46:23 Optimising Real-World Evidence And Real-World Data
-
02:01 Using Real-World Data for FDA Regulatory Decision-Making
-
4:41:50 The State of Real-World Evidence Policy
-
48:18 Perspectives on Real-World Evidence: Assessing Its Use, Impact, and Role in the US and EU
-
02:17 Real World Evidence
-
1:32:09 An International Framework for Real-World Evidence Day 1: RWE Pilot Project Results
-
8:58:15 FDA Regulatory Education for Industry (REdI) – Devices and Biologics Track
-
59:29 Case Examples of Patient Centered Real World Evidence
-
02:42 Real-World Evidence: How Does It Differ From Randomized Controlled Trials?
-
58:15 The Role of Real World Evidence in Regulatory Decision Making
-
01:41 Drugs Biologics and Medical Devices regulatory affairs training course